The Law Offices of Vincent Wong are investigating the Board of Directors of Immucor, Inc. (NASDAQ: BLUD) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to TPG Capital. TPG Capital will pay Immucor shareholders $27.00 in cash per share. The transaction has a total value of approximately $1.973 billion. For more information, click here: http://www.wongesq.com/immucor-inc.html. The investigation concerns whether the Immucor Board of Directors breached their fiduciary duties to Immucor stockholders by failing to adequately shop the Company before entering into this transaction and whether TPG Capital is underpaying for Immucor shares. According to Thomson/First Call, at least one analyst set a price target for Immucor stock at $28.00 per share. If you own common stock in Immucor and wish to obtain additional information, please contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.584.2740, or visit http://www.wongesq.com/immucor-inc.html. Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Shares of Immucor (Nasdaq:BLUD) have taken a tremendous swing upward. The stock is trading at $26.96 as of 9:31 a.m. ET, 30.1% above Friday's closing price of $20.73. Volume is at 1.8 million, 3.9 times the daily average of 464,400.